Growth of LNCaP cells in monoculture and coculture with osteoblasts and response to tNOX inhibitors

Cancer Letters

Volumn 225, Issue 1, 2005, Pages 35-40

  Axanova, Linara ^a   Morré, D James ^b   Morré, Dorothy M ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

( ) Epigallocatechin 3 gallate (EGCg); Capsaicin; Capsibiol T; Coculture; LNCaP prostate cancer cells; Osteoblasts; Phenoxodiol

Indexed keywords

ANTINEOPLASTIC AGENT; CAPSAICIN; CAPSIBIOL T; CISPLATIN; ENZYME INHIBITOR; EPIGALLOCATECHIN GALLATE; PACLITAXEL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; TUMOR ASSOCIATED REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BONE METASTASIS; CANCER INHIBITION; CELL LINE; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; DRUG ANTAGONISM; ENZYME INHIBITION; FETUS; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MONOCULTURE; OSTEOBLAST; PRIORITY JOURNAL; PROSTATE CANCER;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; BONE NEOPLASMS; CAPSAICIN; CATECHIN; CELL SURVIVAL; CISPLATIN; HUMANS; ISOFLAVONES; MALE; OSTEOBLASTS; PACLITAXEL; PLANT EXTRACTS; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 19544381048     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.11.017     Document Type: Article

References (19)

1. M.A. Rubin, M. Putzi, N. Mucci, D.C. Smith, K. Wojno, S. Korenchuk, and K.J. Pienta Rapid ("warm") autopsy study for procurement of metastatic prostate cancer Clin. Cancer Res. 6 2000 1038 1045
2. H.I. Scher, and L.W. Chung Bone metastases: improving the therapeutic index Semin. Oncol. 21 1994 630 656
3. D.J. Morré, and D.M. Morré Cell surface NADH oxidases (ECTO-NOX proteins) with roles in cancer, cellular time-keeping, growth, aging and neurodegenerative disease Free Radical Res. 37 2003 795 808
4. D.J. Morré NADH oxidase: a multifunctional ectoprotein of the eukaryotic cell surface H. Asard A. Bérczi R.J. Caubergs Plasma Membrane Redox Systems and Their Role in Biological Stress and Disease 1998 Kluwer Dordrecht 121 156
5. M. Bruno, A.O. Brightman, J. Lawrence, D. Werderitsh, D.M. Morré, and D.J. Morré Stimulation of NADH oxidase activity from rat liver plasma membranes by growth factors and hormones is decreased or absent with hepatoma plasma membranes Biochem. J. 284 1992 625 628
6. A. del Castillo-Olivares, F. Yantiri, P.-J. Chueh, S. Wang, M. Sweeting, and D. Sedlak A drug-responsive and protease-resistant peripheral NADH oxidase complex from the surface of HeLa S cells Arch. Biochem. Biophys. 358 1998 125 140
7. D.J. Morré, and T. Reust A circulating form of NADH oxidase activity responsive to the antitumor sulfonylurea (N-4-methylphenylsulfonyl)- N′-(4-chlorophenyl)urea (LY181984) specific to sera from cancer patients J. Bioenerg. Biomembr. 29 1997 281 289
8. D.J. Morré, S. Caldwell, A. Mayorga, L.-Y. Wu, and D.M. Morré NADH oxides activity from sera altered by capsaicin is widely distributed among cancer patients Arch. Biochem. Biophys. 342 1997 224 230
9. P.-J. Chueh, C. Kim, N. Cho, D.M. Morré, and D.J. Morré Molecular cloning and characterization of a tumor-associated, growth-related, and time-keeping hydroquinone (NADH) oxidase (tNOX) of the HeLa cell surface Biochemistry 41 2002 3732 3741
10. D.J. Morré, A. Bridge, L.-Y. Wu, and D.M. Morré Preferential inhibition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture Biochem. Pharmacol. 60 2000 937 946
11. D.J. Morré, P.-J. Chueh, and D.M. Morré Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture Proc. Natl Acad. Sci. USA 92 1995 1831 1835
12. D.J. Morré, and D.M. Morré Synergistic Capsicum-tea mixtures with anticancer activity J. Pharm. Pharmacol. 55 2003 987 994
13. H.L. Lee, K.J. Pienta, W.J. Kim, and C.R. Cooper The effect of bone-associated growth factors and cytokines on the growth of prostate cancer cells derived from soft tissue versus bone metastases in vitro Int. J. Oncol. 22 2003 921 926
14. C. Obasaju, and G.R. Hudes Paclitaxel and docetaxel in prostate cancer Hematol. Oncol. Clin. North Am. 15 2001 525 545
15. T. Boulikas, and M. Vougiouka Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review) Oncol. Rep. 11 2004 559 595
16. D.J. Morré, D.M. Morré, H. Sun, R. Cooper, J. Chang, and E.M. Janle Tea catechin synergies in inhibition of cancer cell proliferation and of a cancer specific cell surface oxidase (ECTO-NOX) Pharmacol. Toxicol. 92 2003 234 241
17. G.D. Roodman Mechanisms of bone metastases N. Eng. J. Med. 350 2004 1655 1664
18. R.R. Berges, J. Vukanovic, J.I. Epstein, M. CarMichel, L. Cisek, and D.E. Johnson Implication of cell kinetic changes during the progression of human prostatic cancer Clin. Cancer Res. 1993 473 480
19. J. Pinski, A. Parikh, G.S. Bova, and J.T. Isaacs Therapeutic implications of enhanced G(0)/G(1) checkpoint control induced by coculture of prostate cancer cells with osteoblasts Cancer Res. 2001 6372 6376